Log In|Sign Up
EN
A human BCL2 gene under regulatory control of Eno2 was used for the transgene. Transgene expression was verified by Western blot analysis. Immunohistochemistry showed that transgene expression was restricted to neurons. The Eno2 promoter was used to target transgene expression to neurons. The Eno2 promoter is active as early as embryonic day E10. (J:26571, J:40682)
Basic Information
Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Gene Expression
Related Disease
Reference
Phenotypes
Legend：
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes：
Show/Hide columns
| Phenotypes |
|---|
References Literature
Title
PMID
Journal
Year
IF
